OncoNano Medicine Appoints Dr. Kartik Krishnan as CEO and Dr. Melissa Paoloni as COO
PRIVATEMar 01, 2024
Company
OncoNano Medicine
DallasBiotechnologyHealth CareMedicalTherapeutics
Description
OncoNano Medicine, Inc. appoints Dr. Kartik Krishnan, MD, PhD as Chief Executive Officer (CEO) and member of the Board of Directors
Company Information
Company
OncoNano Medicine
Location
3060 Pegasus Park Drive
Dallas, Texas, United States
About
OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of various payloads from small molecules to large biologics through encapsulation and localized tumor targeting.
Fundz sees it the moment OncoNano Medicine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.